HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EIF5A2 is a novel chemoresistance gene in breast cancer.

AbstractBACKGROUND:
The eIF5A2 gene (encoding the eukaryotic initiation factor 5A2) located at 3q26 is a putative oncogene that is overexpressed in colon and rectal carcinomas, lung cancer and hepatocellular carcinoma. EIF5A2 overexpression correlates significantly with tumor metastasis and is an adverse prognostic marker. However, eIF-5A2 overexpression in breast cancer and its effect on chemotherapy are unknown.
METHODS:
We measured eIF-5A2 expression and doxorubicin sensitivity in different human breast cancer cell lines (Bcap-1937, HCC1937, and MCF-7). To investigate a role for eIF-5A2 in chemoresistance, cells were treated with eIF-5A2-siRNA, exposed to various concentrations of doxorubicin, and toxicity was assayed by CCK-8 (cell counting kit).
RESULTS:
The eIF-5A2 expression levels varied among breast cancer cells. Higher expression levels correlated with decreased doxorubicin sensitivity. Silencing of eIF-5A2 significantly improved doxorubicin toxicity in all three breast cancer cell lines.
CONCLUSION:
This study shows that eIF-5A2 plays an important role in doxorubicin chemoresistance in breast cancer cells.
AuthorsYu Liu, Feiya Du, Wei Chen, Minya Yao, Kezhen Lv, Peifen Fu
JournalBreast cancer (Tokyo, Japan) (Breast Cancer) Vol. 22 Issue 6 Pg. 602-7 (Nov 2015) ISSN: 1880-4233 [Electronic] Japan
PMID24638963 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Peptide Initiation Factors
  • RNA, Small Interfering
  • RNA-Binding Proteins
  • eukaryotic translation initiation factor 5A
  • Doxorubicin
Topics
  • Antibiotics, Antineoplastic (pharmacology)
  • Breast Neoplasms (drug therapy, genetics, pathology)
  • Cell Line, Tumor (drug effects)
  • Doxorubicin (pharmacology)
  • Drug Resistance, Neoplasm (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Gene Knockdown Techniques
  • Humans
  • MCF-7 Cells (drug effects)
  • Peptide Initiation Factors (genetics, metabolism)
  • RNA, Small Interfering
  • RNA-Binding Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: